Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis.
about
Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivoHormonal contraception and risk of cancer.Oral contraceptive use among women in the military and the general U.S. populationCombined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risksMeta-analysis: excess mortality after hip fracture among older women and men.Pathogenesis and clinical management of hereditary non-polyposis colorectal cancer.Polycystic ovary syndrome: current status and future perspective10. Cancers attributable to exposure to hormones in the UK in 2010.The epidemiology of endometrial and ovarian cancer.Nondaily hormonal contraception: considerations in contraceptive choice and patient counseling.Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2).The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.Contraception in women over 40 years of ageRisk factors for developing endometrial cancer after benign endometrial sampling.Molecular pathogenesis of endometrial and ovarian cancer.Past oral contraceptive use and current dietary soy isoflavones influence estrogen metabolism in postmenopausal monkeys (Macaca fascicularis).Contraceptive options during perimenopause.Acne in the adult female patient: a practical approach.Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.Grand multiparity and incidence of endometrial cancer: a population-based study in Finland.Mortality from breast, endometrial and ovarian cancers among grand multiparous women in Taiwan.Could ALDH2*2 be the reason for low incidence and mortality of ovarian cancer for East Asia women?
P2860
Q21092433-E5570451-6B2C-456F-90CB-9B013DA82CD1Q34120493-D099552D-EFCC-4C18-86A8-CD9F768EA7C2Q34132130-EA6346BE-716C-4C70-A37E-54B68270D0ECQ34418632-D5A31812-375E-42C3-85BB-18C15AAE40B5Q34443074-E28F7CAF-4D96-4CA1-9FD5-436245FAA30BQ34975960-7DB5372B-3EE2-4872-B227-0DE796D6DABFQ35124537-3C103F35-C2A2-429C-94FC-86BE1A79E71EQ35654702-310BAF44-BC32-444F-884A-1770066CAAA6Q35676052-CDED4A27-F3E8-4C3A-90D3-D3C0C739B25EQ35841441-9D7BED65-9761-4269-B726-E8982DF3CD6DQ35926568-55C7E17D-B367-4CF9-9463-F9A30E0801C7Q36447526-4B4A916B-7EE0-45BD-8C9A-55AF44DD6F50Q36767323-D9E65516-B8BE-47ED-A91F-E4F38BA97EE0Q37012331-5696242D-779B-44BA-A010-1D92CFA95EE1Q37293672-32242438-29AC-4FB5-966F-F12B411936F0Q37300356-D480144D-28F7-42EA-8506-7EEFD6892555Q37608428-75FDEA43-2DB2-4A3F-9DED-9C1D036A90BDQ38045005-879920AA-9D19-4139-8B1B-8BAE7ACF88F0Q38788210-B8227875-BB46-4005-94A8-F5327F8E5EEBQ43956037-3C090422-1050-4B11-8028-645D67D2D629Q51414790-EA718599-61C9-40A7-8D03-70642EB00075Q53701146-09019159-58E1-4777-8D1C-804E8F0FE9C8
P2860
Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Risk of endometrial cancer in ...... oner's guide to meta-analysis.
@en
type
label
Risk of endometrial cancer in ...... oner's guide to meta-analysis.
@en
prefLabel
Risk of endometrial cancer in ...... oner's guide to meta-analysis.
@en
P356
P1433
P1476
Risk of endometrial cancer in ...... oner's guide to meta-analysis.
@en
P2093
J J Schlesselman
P304
P356
10.1093/HUMREP/12.9.1851
P407
P577
1997-09-01T00:00:00Z